For gene-environment interactions, the timing of the environmental exposure may be critical, say scientists at the M. D. Anderson Cancer Center.
In a unique animal study presented at the American Association for Cancer Research conference, the researchers found that rats susceptible to developing uterine tumors inevitably developed tumors when exposed to an environmental toxin just three days after birth. A single, three-day exposure was enough to “reprogram” the uterus to respond to normal hormonal signals in a way that promoted tumor growth.
The researchers theorize this new model of gene-environment interaction may go some way in explaining why, in a population of people at the same genetic risk, some develop cancer and others don’t.
“In genetically susceptible individuals, exposures that occur early in life may have as great or greater an impact on tumor outcome as those that occur during their adult life,” says the study’s first author, Jennifer Cook.
Molecular biologist Cheryl Walker, the principal investigator on the study, says the finding “establishes developmental programming as a novel type of gene-environment interaction.”
Then, the researchers looked at how uterine tissue in exposed animals responded to normal hormones, and found that “the expression of genes regulated by hormones was abnormally high much of the time,” says Cook. “A short exposure to an environment estrogen reprogrammed the tissue to be super sensitive to hormones, which drives development of these tumors.”
All of the rats shared a common defect in a tumor suppressor gene and had the same genetic susceptibility to developing fibroids, but exposure to the environmental estrogen changed the penetrance of that tumor suppressor gene, and this could theoretically happen within any susceptible population,” says Walker. “Hypothetically, an environmental exposure during development of other organs such as the breast could change the penetrance of human tumor susceptibility genes such as BRCA1. This could offer a clue as to why some women with inherited BRCA1 mutations develop cancer, while others don’t.”